Effect of Xuezhikang, an Extract From Red Yeast Chinese Rice, on Coronary Events in a Chinese Population With Previous Myocardial Infarction

2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults

“…There were no ASCVD outcomes identified for plant sterols, sterol esters, stanols, or stanol esters. A single ASCVD outcomes trial 19 used Xuezhikang, an extract from red yeast Chinese rice, which was not available in the United States during the timeframe for evidence review, so no recommendations were made regarding its use.…”

ESC/EAS Guidelines for the management of dyslipidaemias

“…In one RCT from China in patients with CAD, a partially purified extract of RYR reduced recurrent events by 45%. 144 No other trial has been performed to confirm this finding. A clinically relevant hypocholesterolaemic effect (up to a 20% reduction) is observed with RYR preparations providing a daily dose of 2.5 -10 mg monacolin K. 146 Nutraceuticals containing purified RYR may be considered in people with elevated plasma cholesterol concentrations who do not qualify for treatment with statins in view of their global CV risk.…”

The relationship of (perceived) epistemic cognition to interaction with resources on the internet

“…Alongside this, there were also reports in the popular press (Macrae, 2008) citing research (Lu et al, 2008) on its positive impact, and medical advisory sites providing a science-literacy perspective on this (NHS Choices, 2008). In addition, red yeast rice is widely (correctly) reported as containing the same active ingredient as 'statin' drugs, which have various known side-effects, and have had somewhat controversial coverage in the press in their own right (See, for example, Boseley, 2014;Gallagher, 2014;Ridker & Cook, 2013).…”